Summary
The implication of highly-selective vancomycin usage on the outcome for infants with positive blood cultures for coagulase-negative staphylococci (CONS) was assessed retrospectively. The analysis was performed on partly prospective collected data from infants under 3 months of age with a least one CONS-positive blood culture in the neonatal intensive care unit at the Soroka University Medical Center between 1990 and 1996. During the study period, 239 episodes of CONS-positive blood cultures were identified from among 64,226 live births (3.7 per 1,000). Vancomycin was administered in 22 (9%) episodes, in all cases only after identification of the bacteria. The remaining 217 episodes were managed either without antibiotics or with continuation or initiation of empiric antibiotic therapy (usually ceftazidime±ampicillin) for suspected sepsis. Severity of the initial illness, subsequent morbidity and mortality were low regardless of the treatment administered. Only a single case of a blood-borne vancomycin resistant gram-positive organism was observed during the study period. The approach to CONS-positive blood cultures in neonates used here was associated with low morbidity and mortality. These findings support a policy of highly selective vancomycin usage in an era of emerging vancomycin resistance.
Article PDF
Similar content being viewed by others
References
Herwaldt, L. A., Geiss, M., Kao, C., Pfaller, M. A.: The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin. Infect. Dis. 22 (1996), 14–20.
St. Geme, J. W., Bell, L. M., Baumgart, S., D'Angio, C. T., Harris, M. C.: Distinguishing sepsis from blood culture contamination in young infants with blood cultures growing coagulase-negative staphylococci. Pediatrics 86 (1990) 157–162.
Hammerberg, O., Bialkowska-Hobrzanska, H., Gregson, D., Potters, H., Gopaul, D., Reid, D.: Comparison of blood cultures with corresponding venipuncture site cultures of specimens from hospitalized premature neonates. J. Pediatr. 120 (1992) 120–124.
Freeman, J., Platt, R., Epstein, N. F., Smith, N. E., Sidebottom, D. G., Goldman, D. A.: Birth weight and length of stay as determination of nosocomial coagulase-negative staphylococcal bacteremia in neonatal intensive care unit populations: potential for confounding, Am. J. Epidemiol. 132 (1990) 1130–1140.
Hall, S. L.: Coagulase-negative staphylococcal infections in neonates, Pediatr. Infect. Dis. J. 10 (1991) 57–67.
Kacica, M. A., Horgan, M. J., Ochoa, L., Sandler, R., Lepow, M. L., Venezia, R.: Prevention of gram-positive sepsis in neonates weighing less than 1,500 grams. J. Pediatr 125 (1994) 253–258.
St. Geme, J. W., Harris, M. C.: Coagulase-negative staphylococcal infection in the neonate. Clin. Perinatol. 18 (1991) 281–302.
Lyytikäinen, O., Saxén, H., Ryhänen, R., Vaara, M., Vuoplo-Varkila, J.: Persistence of a multiresistant clone ofStaphylococcus epidermidis in a neonatal intensive-care unit for a four-year period. Clin. Infect. Dis. 20 (1995) 24–29.
Nataro, J. P., Corcoran, L., Zirin, S., Swink, S., Taichman, N., Goin, J., Harris, M. C.: Prospective analysis of infection in hospitalized infants. J. Pediatr. 125 (1994) 798–804.
Barefield, E. S., Philips, J. B.: Vancomycin prophylaxis for coagulase-negative staphylococci bacteremia. J. Pediatr. 125 (1994) 230–232.
Edwards, M. S.: Coagulase-negative staphylococcal bacteremia in neonates: confusion continued. Pediatrics 86 (1990) 320–322.
Shinefield, H. R.: Staphylococcal infections. In:Remington, J., Klein, J. O. (eds.), Infectious diseases of the fetus and newborn infant. W.B. Saunders, Philadelphia 1995, pp. 1105–1141.
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., Hughes, J. M.: CDC definition for nosocomial infections. Am. J. Infect. Control 16 (1988) 128–140.
Rupp, M. E., Archer, G. L.: Coagulase-negativeStaphylococcus: pathogens associated with medical progress, Clin. Infect. Dis. 19 (1994) 231–245.
Patrick, C. C.: Coagulase-negativeStaphylococcus: pathogens with increasing clinical significance, J. Pediatr. 116 (1990) 497–507.
John, J. F. Jr.,McNeil, W. F.: Activity of cephalosporins against methicillin-susceptible and methicillin-resistant coagulase-negative staphylococci: minimal effect of β-lactamases. Antimicrob. Agents Chemother. 17 (1980) 179–183.
Johnson, A. P., Uttley, A. H., Woodford, N., George, R. C.: Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin. Microbiol. Rev. 3 (1990) 280–291.
Fidalgo, S., Vázquez, F., Mendoza, M. C., Pérez, F., Méndez, F. J.: Bacteremia due toStaphylococcus epidermidis: microbiologic, epidemiologic, clinical and prognostic features, Rev. Infect. Dis. 12 (1990) 520–528.
Ringberg, H., Thorén, A., Bredberg, A.: Evaluation of coagulase-negative staphylococci in blood cultures: a prospective clinical and microbiological study. Scand. J. Infect. Dis. 23 (1991) 315–323.
Kirchhoff, L. V., Sheagren, J. N.: Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus. Infect. Control 6 (1985) 479–486.
Radwell, R. L., Leslie, A. L., Tudephope, D. I.: Early diagnosis of neonatal sepsis using hematologic scoring system. J. Pediatr. 112 (1988) 761–767.
Baumgart, S., Hall, S. E., Campos, J. M., Polin, R. A.: Sepsis with coagulase-negative staphylococci in critically ill newborns. Am. J. Dis. Child 137 (1983) 461–463.
Leibovici, L., Gransden, W. R., Eykyn, S. J., Konsiberger, H., Drucker, M., Pitlik, S. D., Phillips, I.: Clinical index to predict bacteremia caused by staphylococci. J. Int. Med. 234 (1993) 83–89.
Greenberg, D., Shinwell, E. S., Yagupsky, P., Greenberg, S., Leibovitz, E., Mazor, M., Dagan, R.: A prospective study of neonatal sepsis and meningitis in Southern Israel. Pediatr. Infect. Dis. J. 16 (1997) 768–773.
Klein, J. O., Marcy, S. M.: Bacterial sepsis and meningitis. In:Remington, J., Klein, J. O. (eds.), Infectious diseases of the fetus and newborn infant. W. B. Saunders, Philadelphia 1995, pp. 835–890.
De Leon, S. P., Wenzel, R. P.: Hospital-acquired bloodstream infections withStaphylococcus epidermidis: review of 100 cases. Am J. Med. 77 (1984) 639–644.
Martin, M. A., Pfaller, M. A., Wenzel, R. P.: Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Am. Intern. Med. 110 (1989) 9–16.
Freeman, J., Epstein, M. F., Smith, N. E., Platt, R., Sidebotto, G., Goldman, D. A.: Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations. Am. J. Dis. Child 144 (1990) 324–329.
Leclerq, R., Courvalin, P.: Resistance to glycopeptide in enterococci. Clin. Infect. Dis. 24 (1997) 545–556.
Sinkowitz, R. L., Keyserling, H., Walker, T. J., Holland, J., Jarvis, W. R.: Epidemiology of vancomycin usage at children's hospital, 1993 through 1995. Pediatr. Infect. Dis. J. 16 (1997) 485–489.
Noble, W. C., Virani, Z., Cree, R. G.: Co-transfer of vancomycin and other resistance genes fromEnterococcus faecalis NCTC 12201 toStaphylococcus aureus. FEMS Microbiol. Lett. 72 (1992) 195–198.
Centers for Disease Control:Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. MMWR 46 (1997) 765–766.
Lyytikäinen, O., Vaara, M., Järviluma, E., Rosenqvist, K., Tüttanen, L., Valtonen, V.: Increased resistance amongStaphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 133–138.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matrai-Kovalskis, Y., Greenberg, D., Shinwell, E.S. et al. Positive blood cultures for coagulase-negative staphylococci in neonates: Does highly selective vancomycin usage affect outcome?. Infection 26, 85–92 (1998). https://doi.org/10.1007/BF02767766
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02767766